Allen Investment Management LLC maintained its position in athenahealth, Inc. (NASDAQ:ATHN) during the third quarter, Holdings Channel reports. The fund owned 4,137 shares of the company’s stock at the end of the third quarter. Allen Investment Management LLC’s holdings in athenahealth were worth $522,000 as of its most recent SEC filing.
A number of other institutional investors also recently added to or reduced their stakes in ATHN. Morgan Stanley boosted its position in shares of athenahealth by 3.1% in the third quarter. Morgan Stanley now owns 3,582,728 shares of the company’s stock worth $451,854,000 after buying an additional 108,646 shares in the last quarter. Riverbridge Partners LLC boosted its position in shares of athenahealth by 9.4% in the third quarter. Riverbridge Partners LLC now owns 1,072,483 shares of the company’s stock worth $135,261,000 after buying an additional 92,178 shares in the last quarter. BlackRock Institutional Trust Company N.A. boosted its position in shares of athenahealth by 0.9% in the third quarter. BlackRock Institutional Trust Company N.A. now owns 973,812 shares of the company’s stock worth $122,817,000 after buying an additional 8,935 shares in the last quarter. HHR Asset Management LLC boosted its position in shares of athenahealth by 3.9% in the second quarter. HHR Asset Management LLC now owns 656,452 shares of the company’s stock worth $90,597,000 after buying an additional 24,666 shares in the last quarter. Finally, Northern Trust Corp boosted its position in shares of athenahealth by 2.9% in the third quarter. Northern Trust Corp now owns 456,464 shares of the company’s stock worth $57,568,000 after buying an additional 12,669 shares in the last quarter.
athenahealth, Inc. (NASDAQ:ATHN) opened at 113.88 on Friday. The stock has a 50 day moving average of $116.99 and a 200 day moving average of $115.49. The company has a market cap of $4.50 billion, a price-to-earnings ratio of 219.00 and a beta of 1.77. athenahealth, Inc. has a 52 week low of $90.11 and a 52 week high of $143.85.
athenahealth (NASDAQ:ATHN) last posted its quarterly earnings results on Thursday, February 2nd. The company reported $0.62 EPS for the quarter, beating the Zacks’ consensus estimate of $0.51 by $0.11. The business earned $288.20 million during the quarter, compared to the consensus estimate of $303.72 million. athenahealth had a return on equity of 6.41% and a net margin of 1.94%. athenahealth’s revenue for the quarter was up 11.9% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.45 earnings per share. Equities research analysts predict that athenahealth, Inc. will post $2.48 earnings per share for the current fiscal year.
WARNING: This piece of content was originally reported by sleekmoney and is owned by of sleekmoney. If you are viewing this piece of content on another publication, it was stolen and reposted in violation of international trademark & copyright legislation. The legal version of this piece of content can be viewed at http://sleekmoney.com/allen-investment-management-llc-has-522000-stake-in-athenahealth-inc-athn/1655718.html.
A number of equities analysts have recently issued reports on ATHN shares. Jefferies Group LLC increased their price objective on shares of athenahealth from $105.00 to $110.00 and gave the company an “underperform” rating in a research note on Friday, October 14th. Oppenheimer Holdings, Inc. set a $170.00 price objective on shares of athenahealth and gave the company a “buy” rating in a research note on Thursday, October 20th. Canaccord Genuity restated a “hold” rating and issued a $127.00 price objective on shares of athenahealth in a research note on Sunday, October 23rd. Morgan Stanley cut shares of athenahealth from an “overweight” rating to an “equal weight” rating and dropped their price objective for the company from $153.00 to $117.00 in a research note on Wednesday, October 26th. Finally, J P Morgan Chase & Co cut shares of athenahealth from an “overweight” rating to a “neutral” rating and dropped their price objective for the company from $128.00 to $111.00 in a research note on Friday, October 28th. Two research analysts have rated the stock with a sell rating, eight have assigned a hold rating and eleven have assigned a buy rating to the company’s stock. athenahealth currently has an average rating of “Hold” and an average price target of $132.79.
In related news, Director John A. Kane sold 2,875 shares of the business’s stock in a transaction dated Friday, January 27th. The stock was sold at an average price of $123.11, for a total value of $353,941.25. Following the completion of the transaction, the director now owns 8,958 shares of the company’s stock, valued at $1,102,819.38. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CEO Jonathan Bush sold 8,000 shares of the business’s stock in a transaction dated Thursday, December 15th. The shares were sold at an average price of $120.00, for a total value of $960,000.00. Following the completion of the transaction, the chief executive officer now directly owns 312,109 shares of the company’s stock, valued at approximately $37,453,080. The disclosure for this sale can be found here. In the last ninety days, insiders sold 19,875 shares of company stock valued at $2,345,866. 3.04% of the stock is owned by insiders.
athenahealth, Inc is a provider of cloud-based services and mobile applications for medical groups and health systems. The Company delivers cloud-based services for revenue cycle management and medical billing, electronic health records (EHR), patient engagement, care coordination, order transmission, population health management, and clinical decision support.
Want to see what other hedge funds are holding ATHN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for athenahealth, Inc. (NASDAQ:ATHN).
This story was originally published by sleekmoney (http://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://sleekmoney.com/allen-investment-management-llc-has-522000-stake-in-athenahealth-inc-athn/1655718.html
Receive News & Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related companies with MarketBeat.com's FREE daily email newsletter.